We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App





Abbott Demonstrates Core Diagnostics Solutions Consisting of Innovative Systems, Automation and Informatics at AACC 2021

By LabMedica International staff writers
Posted on 29 Sep 2021
Print article
Image: Abbott Demonstrates Core Diagnostics Solutions Consisting of Innovative Systems, Automation and Informatics at AACC 2021 (Photo courtesy of Abbott Diagnostics)
Image: Abbott Demonstrates Core Diagnostics Solutions Consisting of Innovative Systems, Automation and Informatics at AACC 2021 (Photo courtesy of Abbott Diagnostics)

Abbott Diagnostics (Lake Bluff, IL, USA) displayed its leading-edge technology at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo with demonstrations of its innovative systems, automation and informatics.

Abbott’s innovative solutions on display at AACC 2021 included Alinity Systems, total laboratory automation and AliniQ Informatics and Professional Services. The company also showed how labs can create an agile strategy with The Abbott Transformation System and the invaluable answers that it placed in the hands of doctors, clinicians and caregivers at the Point of Care.

Abbott’s Alinity family comprises next-generation systems across immunoassay, clinical chemistry, point of care, hematology, blood and plasma screening and molecular diagnostics. On display at the event were the Alinity ci-series integrated clinical chemistry & immunoassay system, Alinity c clinical chemistry system, ALINITY I immunoassay system, and the Alinity m fully integrated, automated, high-throughput molecular diagnostics analyzer. Each Alinity system includes a number of features to help institutions, clinicians and laboratorians better navigate through a pressure-packed health care environment. Designed with universal, intuitive interfaces as well as common software and hardware, Abbott's Alinity systems have the ability to work together, providing greater capacity and simplifying the user experience. Several of the platforms are designed to run more tests in less space, generate test results faster and minimize human errors.

At AACC 2021, Abbott also highlighted its synergistic suite of automation and high volume end-to-end solutions that deliver seamless productivity across the entire laboratory. This included the ACCELERATOR a3600 total laboratory automation system that provides the power and flexibility to meet the needs of the laboratory, both today and in the future. Combined with informatics and lean principles, the ACCELERATOR a3600 maximizes efficiency by providing consistent, predictable sample management and helps improve patient care by minimizing opportunities for error.

Additionally, Abbott demonstrated how its AlinIQ suite of professional services can help labs uncover intelligent insights from their laboratory data and discover greater operational productivity with existing resources. For instance, Abbott’s The AlinIQ Always On services deliver predictive alerts to labs, enabling the detection and prevention of instrument downtime up to three days in advance. The AlinIQ AMS (Analyzer Management System) provides labs and hospital networks the ability to integrate different software systems into a single standardized platform to optimize sample processing time, workflow efficiency and quality results. Similarly, the AlinIQ BIS (Business Intelligence System) provides the tools to optimize throughput and capacity of existing systems to help labs absorb volume increases without additional budget. By delivering intelligent insights, AlinIQ BIS helps labs improve operations and operational expense performance and communicate the lab's value to the broader health care organization. The AlinIQ IMS (Inventory Management System), which combines innovative RFID technology and streamlined process consulting, allows labs to get ahead of operational needs, helping avoid shortages of critical items, reduce waste and time taken for manual processes.

Related Links:
Abbott Diagnostics

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics

Print article
AACC

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.